CYTOKINE RELEASE SYNDROME
Clinical trials for CYTOKINE RELEASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CYTOKINE RELEASE SYNDROME trials appear
Sign up with your email to follow new studies for CYTOKINE RELEASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Pre-Dose stop a dangerous immune reaction?
Disease control Recruiting nowThis early-phase trial tests whether giving siltuximab before epcoritamab can prevent cytokine release syndrome (CRS), a common and sometimes severe side effect. About 20 adults with non-Hodgkin lymphoma will receive siltuximab one hour before their first epcoritamab dose. Resear…
Matched conditions: CYTOKINE RELEASE SYNDROME
Phase: PHASE1 • Sponsor: Taylor Brooks • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New pill aims to tame dangerous immune storms from cancer therapy
Disease control Recruiting nowThis study tests a drug called CTO1681 in 54 adults with diffuse large B-cell lymphoma who are about to receive CAR-T therapy. The drug is taken three times daily for 15 days to prevent or reduce cytokine release syndrome, a potentially severe immune reaction. Researchers will mo…
Matched conditions: CYTOKINE RELEASE SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: CytoAgents, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Can a blue dye tame Immunotherapy's dangerous side effects?
Disease control Recruiting nowThis early-phase trial tests whether methylene blue, a dye used in medicine for other conditions, can safely treat two serious side effects of certain cancer immunotherapies: cytokine release syndrome (CRS) and immune-related neurotoxicity (ICANS). The study will enroll 18 adults…
Matched conditions: CYTOKINE RELEASE SYNDROME
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 26, 2026 16:24 UTC
-
Can a tablet or VR headset help cancer patients recover at home?
Symptom relief Recruiting nowThis study tests a home-based telerehabilitation program for adults with lymphoma or myeloma who have received CAR-T cell therapy. Participants use a tablet or VR headset, along with a pulse oximeter and Fitbit, to follow personalized exercise and nutrition plans. The goal is to …
Matched conditions: CYTOKINE RELEASE SYNDROME
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC